Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of enhancer of zeste homolog 2 mutations on the prognosis of patients with myelodysplastic syndrome: A meta-analysis.

Medicine - 21 Aug 2020

Huang Xinyue, Wang Xiaoxue

Abstract excerpt

BACKGROUND: Gene mutations with important prognostic roles have been identified in patients with myelodysplastic syndrome (MDS). Overall, it is not yet fully clear whether enhancer of zeste homolog 2 (EZH2) is affected and contributes to the disease in MDS patients. Thus, we performed a meta-analysis to investigate the effects of EZH2 mutations on the prognosis of patients with MDS. METHODS: We searched...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Case-Control Studies
Share to Enhancer of Zeste Homolog 2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Myelodysplastic Syndromes

Share to Odds Ratio

Share to Prognosis

Share to Survival Analysis

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 32846854
DOI: 10.1097/MD.0000000000021900
PMCID: PMC7447370

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of enhancer of zeste homolog 2 mutations on the prognosis of patients with myelodysplastic syndrome: A meta-analysis.PMID 32846854Read ↗

Prognostic significance of GATA2 in patients with MDS/AML: a systematic review and meta-analysis.Semantic proximity Read ↗

Clinical characteristics and prognostic analysis of gene mutations in Myelodysplastic SyndromeSemantic proximity Read ↗

Immunohistochemical loss of enhancer of Zeste Homolog 2 (EZH2) protein expression correlates with EZH2 alterations and portends a worse outcome in myelodysplastic syndromes.Semantic proximity Read ↗

Prognostic significance of TET2 mutations in myelodysplastic syndromes: A meta-analysis.Semantic proximity Read ↗

Prognostic value of SRSF2 mutations in patients with de novo myelodysplastic syndromes: A meta-analysis.Semantic proximity Read ↗

Prognostic effect of RUNX1 mutations in myelodysplastic syndromes: a meta-analysis.Semantic proximity Read ↗

Mutations in EZH2 are associated with poor prognosis for patients with myeloid neoplasmsSemantic proximity Read ↗

Molecular characterization of EZH2 mutant patients with myelodysplastic/myeloproliferative neoplasms.Semantic proximity Read ↗

Clinical characteristics and outcomes of EZH2-mutant myelodysplastic syndrome: A large single institution analysis of 1774 patients.Semantic proximity Read ↗

Prognostic significance of U2AF1 mutations in myelodysplastic syndromes: a meta-analysis.Semantic proximity Read ↗

Prognostic significance of SRSF2 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: a meta-analysis.Semantic proximity Read ↗

Prognostic value of isocitrate dehydrogenase mutations in myelodysplastic syndromes: a retrospective cohort study and meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.